DexCom (NASDAQ:DXCM) PT Raised to $151.00
DexCom (NASDAQ:DXCM – Get Free Report) had its target price raised by equities research analysts at Raymond James from $147.00 to $151.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ target price would indicate a potential upside of 18.51% […]
More Stories
LY Co. (OTCMKTS:YAHOY) Short Interest Up 76.3% in December
LY Co. (OTCMKTS:YAHOY – Get Free Report) was the recipient of a large increase in short interest during the month...
Rezolve AI (NASDAQ:RZLV) vs. Trade Desk (NASDAQ:TTD) Critical Analysis
Trade Desk (NASDAQ:TTD – Get Free Report) and Rezolve AI (NASDAQ:RZLV – Get Free Report) are both computer and technology...
Comparing Lucid Group (NASDAQ:LCID) & Lotus Technology (NASDAQ:LOT)
Lotus Technology (NASDAQ:LOT – Get Free Report) and Lucid Group (NASDAQ:LCID – Get Free Report) are both mid-cap auto/tires/trucks companies,...
Color Star Technology Co., Ltd. (NASDAQ:ADD) Short Interest Update
Color Star Technology Co., Ltd. (NASDAQ:ADD – Get Free Report) saw a large growth in short interest in December. As...
Carbon Revolution Public Limited (NASDAQ:CREV) Short Interest Update
Carbon Revolution Public Limited (NASDAQ:CREV – Get Free Report) was the target of a large increase in short interest in...
Brokerages Set Waystar Holding Corp. (NASDAQ:WAY) Target Price at $32.90
Shares of Waystar Holding Corp. (NASDAQ:WAY – Get Free Report) have been given a consensus recommendation of “Buy” by the...